Acadian Asset Management
ORKA

Acadian Asset Management’s Oruka Therapeutics ORKA Stock Holding History

Acadian Asset Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,819
Closed -$123K – 1839
2021
Q4 		$123K Buy
+4,819
New +$145K ﹤0.01% 1335
2020
Q3 		– Sell
-1,742
Closed -$138K – 2391
2020
Q2 		$138K Sell
1,742
-627
-26% -$40.9K ﹤0.01% 1620
2020
Q1 		$80K Buy
2,369
+925
+64% +$50.2K ﹤0.01% 1399
2019
Q4 		$99K Hold
1,444
– – ﹤0.01% 1463
2019
Q3 		$93K Hold
1,444
– – ﹤0.01% 1504
2019
Q2 		$128K Buy
1,444
+429
+42% +$38.5K ﹤0.01% 1329
2019
Q1 		$82K Buy
1,015
+304
+43% +$27K ﹤0.01% 1570
2018
Q4 		$51K Buy
711
+80
+13% +$9.93K ﹤0.01% 1422
2018
Q3 		$76K Buy
631
+166
+36% +$21.4K ﹤0.01% 1274
2018
Q2 		$56K Hold
465
– – ﹤0.01% 1369
2018
Q1 		$50K Buy
+465
New +$125K ﹤0.01% 1354

Other funds holding ORKA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Acadian Asset Management's ORKA Position: Q1 2022 in Review

Acadian Asset Management sold out of Oruka Therapeutics (ORKA) in Q1 2022, closing a stake of 4,819 shares — an estimated $123K sold.

Acadian Asset Management first reported a position in ORKA in Q1 2018 and held it in 11 quarters. The position peaked at $138K in Q2 2020. 22 funds tracked by Wall St. Rank hold ORKA as of Q1 2022.

  • Acadian Asset Management reported no remaining Oruka Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Acadian Asset Management sold 4,819 Oruka Therapeutics shares in Q1 2022, an estimated $123K.
  • Acadian Asset Management first reported a position in Oruka Therapeutics in Q1 2018 and held it in 11 quarters.
  • Acadian Asset Management's Oruka Therapeutics position peaked at $138K in Q2 2020.
  • 22 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2022.

Based on Acadian Asset Management's 13F filing for Q1 2022, filed 12 May 2022.